Immunity “badges” proposed by “the bank”!

On April 5, 2020 Edward Dowd heard James Bullard, the Federal Reserve president, state on Face the Nation: “due to technology we could have badges that could determine someone’s immunity“. Edward found it suspicious that a Fed president would have such a solution so quickly and about our health?  A digital ID being justified by a banker, in the name of “health”!

Gates funded paper: Invisible ink quantum dots “tatoo” to check vaccination status

On December 18, 2019, MIT Scientists publish their paper on their development of a new "biocompatible near-infrared quantum dots delivered to the skin by microneedle patches" to record and check for mandated vaccination status. [1] MIT believe “[t]his study presents a novel approach where the medical record is stored and controlled by the patient within the patient’s skin in a minimally invasive and elegant way.” [3, 4] Their justification "Vaccines prevent disease and save lives; however, lack of standardized immunization recordkeeping makes it challenging to track vaccine coverage across the world."  The concept was a "direct request" by Gates himself, and sold as a means to solve "lack of vaccination" problem in the developing nations.   "If we don’t have good data, it’s really difficult to eradicate disease" such as polio and measles Gates said. [2] A step closer to tracking everyone that we were warned about. Microneedle technology was patented in 2011, and quantum dot research was funded by the US intelligence community in 2008.

Study: Coronavirus spreads quickly and sometimes before people have symptoms – “justification” for extreme measures!

"Infectious disease researchers at The University of Texas at Austin studying the novel coronavirus were able to identify how quickly the virus can spread, a factor that may help public health officials in their efforts at containment. They found that time between cases in a chain of transmission is less than a week and that more than 10% of patients are infected by somebody who has the virus but does not yet have symptoms." [1]  Or may not ever develop symptoms! Professor Meyers and her team studied a total of 450 infection reports from 93 Chinese cities and "found more than one in 10 infections were from people who had contracted the virus but were not feeling sick." [2] The speed of an epidemic depends on two things: how many people each case infects (the reproduction number, R0) how long it takes for infection between people to spread (the serial interval).   A short serial interval is harder to control. "This provides evidence that extensive control measures including isolation, quarantine, school closures, travel restrictions and cancellation of mass gatherings may be warranted," Meyers said. "Asymptomatic transmission definitely makes containment more difficult." The research was funded by the U.S. National Institutes of..> READ MORE

China warns that coronavirus “spreads before symptoms show” (1 to 14 days)

China's Health Minister Ma Xiaowei announced that the Wuhan coronavirus "can spread it before they become symptomatic.", meaning people are contagious during the virus' incubation period.  A highly unusual phenomenon and different to SARS-CoV! The incubation period of the new coronavirus "is anywhere from one to 14 days" officials believe. [1, 2] CDC advisor Dr Schaffner said this "means the infection is much more contagious than we originally thought," and "It's much harder to contain a virus -- to track down a patient's contacts and quarantine them immediately -- if the patient was spreading the disease for days or weeks before they even realized they had it." "Without symptoms, a person may not know they have the infection, but still be able to spread it."  The Super-spreader that China's CDC debunked a couple of days ago is back! The authorities are still not clear about the disease source, but have now banned the sale of wildlife in markets and restaurants. Many people believe that it crossed to humans from snakes.
Should you aspirate the needle before administering the vaccine?
Posted inCOVID-19 Vaccines

Needle Aspiration

Following are links surrounding the debate as to whether to aspirate the syringe before injecting a vaccine, especially the COVID-19 vaccines, to ensure the liquid is injected into the muscle tissue and not a vein. If blood is drawn back…
23 June 2022Posted inCOVID-19 Vaccines

Pfizer vaccine batch integrity issues known to regulators

From leaked emails and reports to Trial Site News in June 2022, it indicates that as early as November 10, 2020, the European regulatory agency (EMA) staff, who oversees the evaluation of medicinal products for the European Union, had reason to be concerned about the rushed speed of the regulatory process with respect to robustness of assessment, plus they were aware of potential issues with Pfizer-BioNTech's vaccine batch integrity. The emails reveal that regulatory bodies like the FDA, MHRA, EMA and Health Canada knew of the differences in batches, regarding % mRNA integrity and the presence of uncharacterised fragments of RNA in batches ("impurities"), making the ‘safety and efficacy’ of the COVID-19 vaccine an unknown and could account for the variation in adverse reactions to batch/lot numbers. Knowing these issues the regulators granted various designations of emergency use authorisation a few weeks to months later - which would not pass normal regulation.

UK the first country to authorise a COVID-19 vaccine

On December 2, 2020, the Pfizer-BioNTech COVID-19 vaccine was "temporarily authorised", by UK's Medicines and Healthcare products Regulatory Agency ( MHRA), becoming the first COVID-19 vaccine to be authorised anywhere in the world, "paving the way for mass vaccination". [1, 2] The vaccine was reported to offer "up to 95% protection against Covid-19 illness".  Pfizer's CEO stated on December 3, 2020 that Pfizer don't know if the vaccine will prevent transmission - the entire purpose of a mass vaccination campaign. The governments authorisation "follows months of rigorous clinical trials and a thorough analysis of the data by experts at the MHRA who have concluded that the vaccine has met its strict standards of safety, quality and effectiveness", contradictory to Pfizer FOIA documents. On 30 December "the cheaper and easier-to-distribute Oxford-AstraZeneca  COVID-19 vaccine” was approved.  A third vaccine, produced by Moderna, was approved for use in the UK in January 2021. Finally, Janssen’s single-dose vaccine was approved in May 2021, although it is yet to be used. [1, 2]

EMA grants first CMA for Pfizer COVID-19 vaccine

On December 21, 2020 the European Medicines Agency (EMA) granted Conditional Marketing Authorization (CMA) for the Pfizer-BioNTech COVID-19 vaccine (Comirnaty) following European Medicines Agency (EMA) “positive opinion, to BNT162b2 for active immunisation of individuals aged 16 years and older to prevent COVID-19, which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)” in people from 16 years of age. [1, 2] They stating that "EMA’s human medicines committee (CHMP) has completed its rigorous evaluation of Comirnaty" concluding by consensus that sufficiently robust data on the quality, safety and efficacy of the vaccine are now available to recommend a formal conditional marketing authorisation." In 2022, leaked emails would reveal that there was "concern over accelerated timelines to ensure they would meet the ‘deadline’ for vaccine authorization at the expense of a robust assessment", and there was great pressure placed on the EMA staff by the European Commissioner, Ursula von der Leyen, who had known close ties with Pfizer CEO. [1]